Shanghai Fosun Pharmaceutical (Group) Co Ltd 2017 SR
The report highlights Fosun Pharma's 2017 sustainability efforts, focusing on its '4IN' strategy: Innovation, Internationalization, Integration, and Intelligentization. Key achievements include the acquisition of Gland Pharma and Tridem Pharma, and the listing of Sisram Med in Hong Kong. The company significantly increased R&D investment to RMB 1,529 million, particularly in monoclonal antibodies. Environmental performance improved with a 48.8% reduction in NOx and a 76.3% reduction in SOx emissions. Socially, the company saved over 20 million lives through its anti-malarial drug Artesun and launched the 'Care for Health' program for rural doctors.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2017
Type: SR
Pages: 159
Back to company
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Corporate Social Responsibility Report
The report highlights Fosun Pharma's 2017 sustainability efforts, focusing on its '4IN' strategy: Innovation, Internationalization, Integration, and Intelligentization. Key achievements include the acquisition of Gland Pharma and Tridem Pharma, and the listing of Sisram Med in Hong Kong. The company significantly increased R&D investment to RMB 1,529 million, particularly in monoclonal antibodies. Environmental performance improved with a 48.8% reduction in NOx and a 76.3% reduction in SOx emissions. Socially, the company saved over 20 million lives through its anti-malarial drug Artesun and launched the 'Care for Health' program for rural doctors.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees